Approvals/CIMA-AEMPS/SOLIFENACINA/TAMSULOSINA TEVA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG

Approved

STANDARD

SOLIFENACINA/TAMSULOSINA TEVA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG

Teva B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 5d9962da0b58968d
Drug Cima Aemps Name: SOLIFENACINA/TAMSULOSINA TEVA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG
Register Number: 88721
Holder Company Name: Teva B.V.
Marketing Company Name: Teva Pharma S.L.U.
Holder Company Detail Path: /organization/teva-pharma-b-v
Authorization Date: 2023-03-09
Dosage Form: COMPRIMIDO DE LIBERACIÓN MODIFICADA
Dose: 6 mg/0,4 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Teva B.V.
Company Detail Path: /organization/teva-pharma-b-v

TAMSULOSINA HIDROCLORURO

0,4 mg

SOLIFENACINA SUCCINATO

6 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 9, 2023

Approval ID

5d9962da0b58968d

Type

Standard